Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
Company Details
- Employees
- 83
- Founded
- -
- Address
- Suite G16, National Innovation Centre, Australian Technology Park, 4 Cornwallis Street, Eveleigh,new South Wales 2015,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- speedx.com.au
- Keywords
- PCR, qPCR, Multiplex, Molecular Diagnostics, Clinical Diagnostics, Biotechnology, IVD, PlexZyme, STI, STD, Antibiotic Resistance, Antimicrobial Stewardship, Sexual Health.
- HQ
- Eveleigh, New South Wales
Speedx Pty Ltd Questions
Speedx Pty Ltd's website is speedx.com.au
Speedx Pty Ltd's LinkedIn profile is https://www.linkedin.com/company/speedx-pty-ltd
Speedx Pty Ltd has
83 employees.
View email and phone details for 83
employees at Speedx Pty Ltd.
Speedx Pty Ltd's industry is
Biotechnology Research
Speedx Pty Ltd's top competitors are
Genetic Signatures,
Ausdiagnostics,
Vow,
Syngenis,
Ausbiotech,
Speedx,
Engeneic,
Inventia Life Science,
Pending Ai,
Nutromics.
Speedx Pty Ltd's categories are Biotechnology Research
Speedx Pty Ltd's founding year is 2009
